Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | |
| Negative | |
| Uncertain | |
| Constraining | |
| Legalese | |
| Litigous | |
| Readability |
H.S. sophomore Avg
|
Filing tables
Filing exhibits
Filing view
External links
Exhibit 15.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the registration statements (No. 333-222043, 333-228980, 333-188042 and 333-258819) on Form S-8 of our report dated April 26, 2023, with respect to the consolidated financial statements of CASI Pharmaceuticals, Inc.
/s/ KPMG Huazhen LLP
Beijing, China
April 26, 2023